Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04852705
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

Who this might be right for
COVID-19
Shenzhen Kangtai Biological Products Co., LTD 28,000
Not applicableNot Yet RecruitingNCT07838038
What this trial is testing

Effect of Messaging on Pragmatic Outcomes Within an Integrated Healthcare System

Who this might be right for
Covid-19 Vaccination
Kaiser Permanente 1,300,000
Not applicableStudy completedNCT06036134
What this trial is testing

Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents

Who this might be right for
Vaccine-Preventable DiseasesCOVID-19 PandemicHealth-Related Behavior+2 more
Arizona State University 80
Large-scale testing (Phase 3)UnknownNCT05428592
What this trial is testing

Clinical Trial of SARS-CoV-2 mRNA Vaccine(LVRNA009) as Heterologous Booster in Islamabad

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 1,100
Large-scale testing (Phase 3)Study completedNCT04756271
What this trial is testing

Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection

Who this might be right for
Vaccine Adverse ReactionSeroconversion
Zagazig University 246
Not applicableUnknownNCT04832932
What this trial is testing

The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

Who this might be right for
COVID-19 Vaccines
Mebo Research, Inc. 2,000
Not applicableStudy completedNCT04723706
What this trial is testing

Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients

Who this might be right for
Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
Henry Ford Health System 33
Large-scale testing (Phase 3)UnknownNCT04741061
What this trial is testing

Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light

Who this might be right for
COVID-19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 6,000
Early research (Phase 1)Study completedNCT05585632
What this trial is testing

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Who this might be right for
SARS-CoV-2InfluenzaRSV
ModernaTX, Inc. 392
Not applicableStudy completedNCT04657263
What this trial is testing

Impact of the COVID-19 Pandemic on Vaccination

Who this might be right for
Covid19
University Hospital, Montpellier 500
Post-approval studies (Phase 4)Study completedNCT05303584
What this trial is testing

Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 362
Early research (Phase 1)Study completedNCT04334980
What this trial is testing

Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19

Who this might be right for
COVID-19
Symvivo Corporation 24
Large-scale testing (Phase 3)Study completedNCT05572879
What this trial is testing

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

Who this might be right for
COVID-19
EuBiologics Co.,Ltd 2,600
Not applicableStudy completedNCT05124223
What this trial is testing

Analysis of Cardiac Damage Post Infection With SARS-CoV-2 and Post Vaccination Against COVID-19

Who this might be right for
Myocarditis Acute
Sebastian Kelle 131
Testing effectiveness (Phase 2)Study completedNCT04368988
What this trial is testing

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

Who this might be right for
COVID-19
Novavax 1,419
Testing effectiveness (Phase 2)Study completedNCT05639998
What this trial is testing

BBV152/BBV154 Heterologus Prime-Boost Study

Who this might be right for
Corona Virus Infection
Bharat Biotech International Limited 608
Early research (Phase 1)Study completedNCT06680375
What this trial is testing

An Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

Who this might be right for
COVID-19
GlaxoSmithKline 106
Early research (Phase 1)UnknownNCT05394012
What this trial is testing

A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

Who this might be right for
COVID-19
Walvax Biotechnology Co., Ltd. 120
Not applicableStudy completedNCT04800965
What this trial is testing

Text-based Interventions to Promote COVID-19 Vaccinations

Who this might be right for
Covid19, Vaccines
University of California, Los Angeles 200,000
Testing effectiveness (Phase 2)Study completedNCT04949490
What this trial is testing

A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects

Who this might be right for
COVID-19SARS-CoV-2 Infection
BioNTech SE 137
Next Page